Theranostic Breakthrough: Radioligand Therapy Gains Ground
The radioligand therapy sector has positioned itself as a groundbreaking domain within oncology and rare disease therapeutics, marking a significant evolution toward precision-based medical interventions. This cutting-edge therapeutic approach merges targeting molecules with radioactive isotopes to deliver unparalleled cancer cell specificity while safeguarding healthy tissue. The field...
0 Shares
4024 Views
0 Reviews